> Back to EJC

2016 editions

  • December 2016
    Joao Incio on mechanisms to explain why obesity promotes cancer.
  • November 2016
    Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – September 2015

Loading EJC News Focus video

European Code against Cancer: the inside story

It's incredible to think that 12 bullet points, on a single sheet of A4, could reduce cancer in Europe by more than one-third, possibly by half. But these 12 points are the keys to cancer prevention. The latest edition of the European Code against Cancer was published in October 2014, and its straightforward appearance belies the efforts to ensure that each point is firmly based on science.

Joachim Schüz and Lawrence von Karsa, both from International Agency for Research on Cancer, IARC, Lyon, France are co-editors of a forthcoming Cancer Epidemiology supplement, which details the evidence that underpins the Code. Here, they tell Helen Saul that, since the previous version in 2003, there have been more than half a million publications on cancer prevention. Even so, there was frequently less debate on the science than on how to present it to the public. Christopher Wild, Director of IARC, comments.

The new Code can be found at http://cancer-code-europe.iarc.fr/index.php/en/